What is the total value of India's pharmaceutical export to Finland?

India exported pharmaceuticals worth $366.3K to Finland across 69 verified shipments.

Who are the top Indian pharmaceutical exporters to Finland?

1. Labsystems Diagnostics Oy — $252.4K. 2. LABSYSTEMS DIAGNOSTICS OY — $82.9K. 3. PRIME PHARMACARE LTD — $8.8K. Total: 16 suppliers.

Which companies in Finland import pharmaceuticals from India?

1. TRIVITRON HEALTHCARE PRIVATE LIMITED — $335.3K. 2. INTAS PHARMACEUTICALS LIMITED — $8.8K. 3. RICONPHARMA INDIA PRIVATE LIMITED — $6.4K. 15 buyers total.

What pharmaceutical products does India export most to Finland?

1. Biotin ($338.6K, 92.4%); 2. Telmisartan ($8.8K, 2.4%); 3. Irinotecan ($6.4K, 1.7%); 4. Insulin ($5.5K, 1.5%); 5. Dexamethasone ($1.7K, 0.5%)

Why does Finland import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $366.3K corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Finland?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Finland pharmaceutical trade?

$5.3K per consignment across 69 shipments.

How many Indian pharmaceutical companies export to Finland?

16 Indian companies. Largest: Labsystems Diagnostics Oy with $252.4K.

How can I find verified Indian pharmaceutical suppliers for Finland?

TransData Nexus covers 16 active exporters with shipment history and trade values at transdatanexus.com.

Finland to India Pharmaceutical Import (2026) — $366.3K, 16 Foreign Suppliers | TransData Nexus

Finland to India Pharmaceutical Import (2026) — $366.3K, 16 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Finland to India

#	Formulation	Value	Share
1	Biotin	$338.6K	92.4%
2	Telmisartan	$8.8K	2.4%
3	Irinotecan	$6.4K	1.7%
4	Insulin	$5.5K	1.5%
5	Dexamethasone	$1.7K	0.5%
6	Levofloxacin	$1.7K	0.5%
7	Ofloxacin	$1.7K	0.5%
8	Serum	$1.6K	0.4%
9	Plasma	$145	0.0%
10	Protein	$106	0.0%
11	Calcium	$25	0.0%
12	Simvastatin	$18	0.0%
13	Gabapentin	$13	0.0%
14	Citalopram	$11	0.0%

India imports 14+ pharmaceutical formulations from Finland with a combined trade value of $366.3K. Key products include Biotin ($339K), Telmisartan ($9K), Irinotecan ($6K), Insulin ($6K), Dexamethasone ($2K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 69 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Finland to India Trade Routes

1Biotin$339K

2Telmisartan$9K

3Irinotecan$6K

4Insulin$6K

5Dexamethasone$2K

6Levofloxacin

Top Finland Suppliers to India

1Labsystems Diagnostics Oy

$252K

2Labsystems Diagnostics Oy

$83K

3Prime Pharmacare Ltd

$9K

4Fermion Oy

$6K

5Privaposervices Gmbh

$5K

Trade Statistics

Total Value$366K

Shipments69

Indian Exporters16

Finland Buyers15

Avg Shipment$5K

Products14

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

India–Finland Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Finland and India has experienced modest growth from 2022 to 2026. In 2022, the total import value was approximately $300,000 USD, with 60 shipments from 14 Finnish suppliers to 13 Indian buyers. By 2026, these figures increased to a total import value of $366,000 USD, 69 shipments, 16 Finnish suppliers, and 15 Indian buyers. This steady growth reflects a strengthening bilateral trade relationship in the pharmaceutical sector.

2Finland's Role in India's Pharma Imports

Finland's contribution to India's pharmaceutical imports remains relatively small. In 2026, Finland accounted for approximately 0.1% of India's total pharmaceutical imports. The primary product imported from Finland is biotin, which constituted 92.4% of the total import value. Other imported products include telmisartan, irinotecan, insulin, and dexamethasone, among others.

3Recent Developments

Between 2024 and 2026, the Central Drugs Standard Control Organisation (CDSCO) implemented several policy changes to streamline the import process. These included the introduction of the Sugam portal for online registration and the issuance of guidelines for the import of pharmaceutical products. Additionally, in May 2025, CDSCO announced a special condition under which permission for the import of drugs with residual shelf life less than 60% is allowed, aiming to address supply chain challenges.

Finland Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1CDSCO Registration Process

To import pharmaceutical products into India, Finnish companies must register with the CDSCO. The process involves several key steps:

1. Online Registration: Applicants must register on the CDSCO Sugam portal by providing details such as applicant type, user credentials, and organizational information.

2. Document Submission: Essential documents include a valid address proof of the firm (e.g., Certificate of Incorporation, GST Certificate), a valid ID proof of the authorized person, and an undertaking form.

3. Verification and Approval: After submission, the application is reviewed by CDSCO officials. Upon approval, the applicant receives a registration certificate, authorizing the import of pharmaceutical products into India.

2GMP & Manufacturing Standards

India requires that foreign manufacturing sites adhere to Good Manufacturing Practice (GMP) standards to ensure product quality and safety. Manufacturers must provide a GMP certificate issued by the competent authority in the country of origin. Additionally, the manufacturing facility must be registered with CDSCO, and the site master file should detail the plant layout, manufacturing processes, and quality control measures.

3Import Documentation

Importing pharmaceutical products into India necessitates specific documentation:

Import License (Form 10): Required for the import of drugs and medical devices.

Registration Certificate: Issued by CDSCO, confirming the product's approval for sale in India.

No Objection Certificate (NOC): For certain products, an NOC from the Ministry of Health and Family Welfare may be required.

Test License: Permits the import of drugs for testing, analysis, or clinical trial purposes.

Customs Procedures: Compliance with Indian customs regulations, including payment of applicable duties and taxes.

TransData Nexus Research · Finland regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Finland identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 69 verified shipments from 16 Indian exporters to 15 Finland buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

16 Exporters

15 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Finland to India Pharmaceutical Import

Top Pharmaceutical Formulations — Finland to India

Top Pharmaceutical Products — Finland to India Trade Routes

Top Finland Suppliers to India

Trade Statistics

Other Import Origins

India–Finland Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Finland's Role in India's Pharma Imports

3Recent Developments

Top Indian Buyers from Finland

Product Routes

Full Dataset Access

Finland Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Finland

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Finland

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to Finland Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

Market Opportunity Assessment — Finland for Indian Pharma

1India's Import Dependency

2Finland Companies in India

FAQ — India to Finland Pharmaceutical Trade